MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s12185-013-1383-z

Медицинская библиотека · International journal of hematology · 2013

A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.

Torimoto Yoshihiro, Sato Kazuya, Ikuta Katsuya, Hayashi Toshiaki, Hirayama Yasuo, Inamura Junki, Kobayashi Hajime, Kobayashi Ryoji, Koda Kyuhei, Kurosawa Mitsutoshi, Mori Akio, Ota Shuichi, Sakai Hajime, Shigematsu Akio, Shindo Motohiro, Shinzaki Hitoshi, Takahashi Fumihiko, Takimoto Rishu, Tanaka Junji, Yamamoto Satoshi, Kohgo Yutaka, Fukuhara Takashi

Клиническое исследованиеСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) comprises a group of heterogeneous lymphomas that do not fit any other identified PTCL-subgroup and show poor prognosis. To clarify clinical aspects of Japanese PTCL-NOS patients, the Hokkaido Hematology Study Group conducted a multicenter retrospective analysis. The median age of the 107 patients (male 65.4 %) was 67 years. The majority (82.4 %) had stage III/IV disease. Following the international prognostic index, 65.7 % were categorized as high intermediate or high risk. Primary chemotherapy was selected in 96 (90 %) patients, 86 of whom received anthracycline regimens. Sixteen patients received high-dose chemotherapy with autologous stem cell transplantation. Forty-eight (52 %) of the 92 evaluable patients achieved complete remission (CR) or CR/unconfirmed after the primary treatment, in which 22 (46 %) relapsed. The estimated 5-year overall survival (OS) of all patients was 35 %. Three independent risk factors (RFs) associated with OS, bulky disease (hazard ratio HR = 5.324; p = 0.019), age >60 years (HR = 3.015; p = 0.025), and platelet count less than 10 × 10(4)/μL (HR = 3.999; p = 0.036), were identified in a multivariate analysis. Using these three RFs, the OS curves were significantly stratified into three risk groups (low risk, 0 RFs, 3-year-OS 72 %; intermediate risk, one RF, 30 %; high risk, two or three RFs, 0 %; p = 0.0005). These findings may provide valuable information for the management of Japanese PTCL-NOS patients.

Для цитирования: Torimoto Yoshihiro, Sato Kazuya, Ikuta Katsuya, Hayashi Toshiaki, Hirayama Yasuo, Inamura Junki, Kobayashi Hajime, Kobayashi Ryoji, Koda Kyuhei, Kurosawa Mitsutoshi, Mori Akio, Ota Shuichi, Sakai Hajime, Shigematsu Akio, Shindo Motohiro, Shinzaki Hitoshi, Takahashi Fumihiko, Takimoto Rishu, Tanaka Junji, Yamamoto Satoshi, Kohgo Yutaka, Fukuhara Takashi. A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.. International journal of hematology. 2013. DOI: 10.1007/s12185-013-1383-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.